Maris JM - Search Results

1

Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.

Cimmino F, Avitabile M, Diskin SJ, Vaksman Z, Pignataro P, Formicola D, Cardinale A, Testori A, Koster J, de Torres C, Devoto M, Maris JM, Iolascon A, Capasso M. Cimmino F, et al. Among authors: maris jm. Int J Cancer. 2018 Dec 1;143(11):2828-2837. doi: 10.1002/ijc.31822. Epub 2018 Oct 4. Int J Cancer. 2018. PMID: 30132831 Free PMC article.

2

No CDKN2 mutations in neuroblastomas.

Beltinger CP, White PS, Sulman EP, Maris JM, Brodeur GM. Beltinger CP, et al. Among authors: maris jm. Cancer Res. 1995 May 15;55(10):2053-5. Cancer Res. 1995. PMID: 7743501

3

Familial predisposition to neuroblastoma does not map to chromosome band 1p36.

Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Yanofsky RA, Feldman GL, Brodeur GM. Maris JM, et al. Cancer Res. 1996 Aug 1;56(15):3421-5. Cancer Res. 1996. PMID: 8758905

4

Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma.

White PS, Maris JM, Sulman EP, Jensen SJ, Kyemba SM, Beltinger CP, Allen C, Kramer DL, Biegel JA, Brodeur GM. White PS, et al. Among authors: maris jm. Eur J Cancer. 1997 Oct;33(12):1957-61. doi: 10.1016/s0959-8049(97)00311-0. Eur J Cancer. 1997. PMID: 9516832

5

Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene?

Maris JM, Jensen J, Sulman EP, Beltinger CP, Allen C, Biegel JA, Brodeur GM, White PS. Maris JM, et al. Eur J Cancer. 1997 Oct;33(12):1991-6. doi: 10.1016/s0959-8049(97)00279-7. Eur J Cancer. 1997. PMID: 9516840

6

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.

Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS. Thompson PM, et al. Among authors: maris jm. Cancer Res. 2001 Jan 15;61(2):679-86. Cancer Res. 2001. PMID: 11212268

7

Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.

Maris JM, Weiss MJ, Mosse Y, Hii G, Guo C, White PS, Hogarty MD, Mirensky T, Brodeur GM, Rebbeck TR, Urbanek M, Shusterman S. Maris JM, et al. Cancer Res. 2002 Nov 15;62(22):6651-8. Cancer Res. 2002. PMID: 12438263

8

ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

Wang Q, Hii G, Shusterman S, Mosse Y, Winter CL, Guo C, Zhao H, Rappaport E, Hogarty MD, Maris JM. Wang Q, et al. Among authors: maris jm. Cancer Res. 2003 Apr 1;63(7):1631-5. Cancer Res. 2003. PMID: 12670915

9

High-resolution detection and mapping of genomic DNA alterations in neuroblastoma.

Mosse YP, Greshock J, Margolin A, Naylor T, Cole K, Khazi D, Hii G, Winter C, Shahzad S, Asziz MU, Biegel JA, Weber BL, Maris JM. Mosse YP, et al. Among authors: maris jm. Genes Chromosomes Cancer. 2005 Aug;43(4):390-403. doi: 10.1002/gcc.20198. Genes Chromosomes Cancer. 2005. PMID: 15892104

10

Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era.

Mosse YP, Greshock J, Weber BL, Maris JM. Mosse YP, et al. Among authors: maris jm. Cancer Lett. 2005 Oct 18;228(1-2):83-90. doi: 10.1016/j.canlet.2005.02.052. Cancer Lett. 2005. PMID: 15967571 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

467 results

Search Page

Filters